Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 9
Submit an article Journal homepage
595
Views
20
CrossRef citations to date
0
Altmetric
Treatment Evaluation

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

Arzu Didem YalcinAntalya Training and Research Hospital, Allergy and Clinical Immunology Unit, Antalya, Turkey;Genomics Research Center, Academia Sinica, [email protected]
, MD,
Aykut CilliAkdeniz University Hospital, Department of Pulmonary Medicine, Antalya, Turkey
, MD,
Atil BisginFaculty of Health Sciences, Linkoping University, Department of Clinical and Experimental Medicine, Linkoping, Sweden
, MD PhD,
Ludwig G StraussGerman Cancer Research Center, Clinical Cooperation Unit Nuclear Medicine, Heidelberg, Germany
, MD &
Felix HerthUniversity of Heidelberg, Thoraxklinik Translational Lung Research Center, Department of Pulmonary and Critical Care Medicine, Heidelberg, Germany
, MD PhD
Pages 1335-1341 | Published online: 24 Jul 2013

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Arzu Didem Yalcin & Ata Nevzat Yalcin. (2021) Future perspective: biologic agents in patients with severe COVID-19. Immunopharmacology and Immunotoxicology 43:1, pages 1-7.
Read now
Arzu Didem Yalcin & Ata Nevzat Yalcin. (2020) A case of asthma with Behcet’s disease: successful treatment with omalizumab and its effects on recurrent aphthous lesions. Immunopharmacology and Immunotoxicology 42:4, pages 379-382.
Read now
Arzu Didem Yalcin. (2016) A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacology and Immunotoxicology 38:2, pages 162-166.
Read now
Evgenia Papathanassiou, Stelios Loukides & Petros Bakakos. (2016) Severe asthma: anti-IgE or anti-IL-5?. European Clinical Respiratory Journal 3:1.
Read now
Seda Tural Onur, Arzu Didem Yalcin, Betul Celik & Saadet Gumuslu. (2015) Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients. Journal of Asthma 52:2, pages 123-127.
Read now
Arzu Didem Yalcin, Betul Celik & Saadet Gumuslu. (2014) D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment. Expert Opinion on Biological Therapy 14:3, pages 283-286.
Read now

Articles from other publishers (14)

Junli Guo, Yuanyuan Zhang, Tianxiao Liu, Bruce D. Levy, Peter Libby & Guo-Ping Shi. (2022) Allergic asthma is a risk factor for human cardiovascular diseases. Nature Cardiovascular Research 1:5, pages 417-430.
Crossref
Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, Carlos Prieto & Jesus Sainz. (2021) Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Frontiers in Pharmacology 12.
Crossref
Peipei Liu, Zhongzong Pan, Chunyin Gu, Xiaodan Cao, Xiaowu Liu, Jianjian Zhang, Zheng Xiao, Xueping Wang, Haibing Guo, Dianwen Ju & Su-Jun Deng. (2020) An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Frontiers in Immunology 11.
Crossref
Sevim Baysak, Aysegul Sevim Kecici & Bilal Dogan. (2020) Long‐term follow‐up effect of omalizumab in chronic spontaneous urticaria and its association with serum C‐reactive protein levels. Dermatologic Therapy 33:4.
Crossref
Arzu D. Yalcin & Rusen Uzun. (2019) Anti-IgE Significantly Changes Circulating Interleukin-25, Vitamin-D and Interleukin-33 Levels in Patients with Allergic Asthma. Current Pharmaceutical Design 25:35, pages 3784-3795.
Crossref
Jean-François Lauzon-Joset, David Marsolais, Éliane Tardif-Pellerin, Dany Patoine & Elyse Y. Bissonnette. (2019) CD200 in asthma. The International Journal of Biochemistry & Cell Biology 112, pages 141-144.
Crossref
Betul Celik, Arzu Didem Yalcin, Gizem Esra Genc, Tangul Bulut, Sibel Kuloglu Genc & Saadet Gumuslu. (2016) CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomedical Reports 5:2, pages 259-263.
Crossref
Cong-Lin Liu, Jin-Ying Zhang & Guo-Ping Shi. (2016) Interaction between allergic asthma and atherosclerosis. Translational Research 174, pages 5-22.
Crossref
Arzu Didem Yalcin. (2015) Advances in Anti-IgE Therapy. BioMed Research International 2015, pages 1-11.
Crossref
AD Yalcin. (2014) ANTI-Ige: An Overview. Global Journal of Allergy, pages 003-012.
Crossref
Gennaro D’Amato, Anna Stanziola, Alessandro Sanduzzi, Gennaro Liccardi, Antonello Salzillo, Carolina Vitale, Antonio Molino, Alessandro Vatrella & Maria D’Amato. (2014) Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Saadet Gumuslu. (2014) Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity. Medical Science Monitor 20, pages 1078-1081.
Crossref
Arzu Didem Yalcin. (2014) An Overview of the Effects of anti-IgE Therapies. Medical Science Monitor 20, pages 1691-1699.
Crossref
Erkan Alpsoy. (2013) There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders. Medical Science Monitor 19, pages 888-891.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.